Thus, in IBD, JNK1 does not significantly affect the intestinal epithelium, while JNK2 suppression leads to immune cell proliferation by dysregulation of apoptosis, leading to inflammatory activation. The gene discussed is MAPK9; the disease is inflammatory bowel disease.